Liquidia Technologies: Funding, Investors & Team (Oct 2026)
Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
Liquidia Technologies has raised $95.0M across 3 funding rounds on record, the most recent an undisclosed round of $25.0M announced in Dec 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Liquidia Technologies Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Liquidia Technologies Funding Rounds
Liquidia Technologies raised $20.0M in a Post-IPO Debt announced in Jan 2022.
3 months later, a Post-IPO Equity of $50.0M was announced in Apr 2022.
1.7 years later, an undisclosed round of $25.0M was announced in Dec 2023.
Liquidia Technologies Founders and Leadership Team
Contact details for the Liquidia Technologies team: 1 of 2 have an email address on file.
Start 14-day free trial →Liquidia Technologies Funding Compared to Other Biotechnology Startups
Liquidia Technologies' latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Liquidia Technologies in Biotechnology and Morrisville
Companies Similar to Liquidia Technologies
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Liquidia Technologies Funding FAQs
What does Liquidia Technologies do?
Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
How much funding has Liquidia Technologies raised?
Liquidia Technologies has raised $95.0M across 3 rounds on record. The most recent is an undisclosed round of $25.0M announced in Dec 2023.
When did Liquidia Technologies last raise funding?
Liquidia Technologies' most recent funding round on record is an undisclosed round of $25.0M, announced in Dec 2023.
Who founded Liquidia Technologies?
FundedIQ lists Seth Rudnick (Founder) at Liquidia Technologies.
Who is the CEO of Liquidia Technologies?
Roger Jeffs is listed as CEO at Liquidia Technologies.
Where is Liquidia Technologies headquartered?
Liquidia Technologies is based in Morrisville, North Carolina, United States.
How many employees does Liquidia Technologies have?
Liquidia Technologies is in the 51-100 employee band.
How does Liquidia Technologies' funding compare to other Biotechnology startups?
Liquidia Technologies' latest round of $25.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Liquidia Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Liquidia Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.